Navigation Links
HUMAN Healthy Vending Expands Into 73 New Markets in 90 Days, Launches Industry-First Healthy Micro-Market Platform
Date:9/13/2013

Los Angeles, CA (PRWEB) September 13, 2013

HUMAN Healthy Vending (http://www.healthyvending.com), the nation’s premier socially-responsible healthy vending franchise, announces that is has expanded throughout 73 new markets in 18 states in just 90 days. HUMAN Healthy Vending machines have launched in the following states: Ala., Ariz., Calif., Colo., Fla., Ga., Ind., Mont., N.C., N.J., Ohio, Okla., Ore., Pa., S.C., Tenn., Texas, and Va.

While the past 90 days show substantial growth in healthy vending machine placements, HUMAN Healthy Vending is also experiencing exponential growth in its number of franchisees, internal staff and revenue. In fact, over the last three years, HUMAN has experienced a sales revenue growth of 2,378%, which landed the company on Inc Magazine’s 2013 “Inc 500 List of Fastest-Growing Private Companies in America.”

Industry-First Platform & Technology

HUMAN is now offering its franchisees an entire platform of potential revenue opportunities and avenues to materialize its goal to make “Easy Nutrition Everywhere.” For example, HUMAN is the first healthy vending company to bring nutrition activism to the corporate world with its new healthy micromarkets. HUMAN’s healthy micro-markets are self-serve natural foods stores integrated seamlessly into an office space. Free to offices that meet minimum qualifications, micro-markets are a great option for workplaces that want to provide a breadth of healthful snack and meal options, improve employee health, boost morale, increase productivity, and slash healt
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New drug prevents spread of human prostate cancer cells
2. Scientists solving the mystery of human consciousness
3. First targeted nanomedicine to enter human clinical studies
4. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
5. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
6. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
7. IBN discovers human neural stem cells with tumor targeting ability
8. RANK protein promotes the initiation, progression and metastasis of human breast cancer
9. CNIO researchers describe new functions of cohesin relevant for human disease
10. New Clues to the Evolution of the Human Brain
11. Humanist funerals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... India Network Foundation sponsors visitor health ... or family visit for the past 25 years. As India Network offers coverage for ... travel and spend time with their children and grand children. India Network specializes ...
(Date:7/30/2015)... ... ... When responsible for the care of an aging loved one, summer vacations ... What happens if mom falls? Who will remind Dad to take his medications? What ... not taking time away from caregiving responsibilities can lead to bigger problems – caregiver ...
(Date:7/30/2015)... ... , ... Committed to helping the next generation succeed - Mercy College is ... the College’s “My Brother’s Keeper Scholarship.” The President’s signature initiative issues a call to ... support they need to think more broadly about their future. Building on what works ...
(Date:7/30/2015)... ... , ... In an effort to provide the twenty four hour continuous care ... his practice. , The decision will also allow him to spend more time in ... his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has always ...
(Date:7/30/2015)... ... 2015 , ... Eyepartner is proud to highlight that their ... Gaslamp Quarter Plaza for five years this September. , The surveillance and ... any suspicious activity. These cameras are in place to provide inarguable proof in ...
Breaking Medicine News(10 mins):Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3
... cerebrovascular disease , MONDAY, Dec. 10 (HealthDay News) -- ... for mild cognitive impairment, says a study by researchers ... City. , Mild cognitive impairment, which causes learning and ... years, particularly as a means of identifying the early ...
... team of researchers from the University of Pennsylvania School ... in the immune system process that fights infection yet, ... tissue., The Penn team, led by Christopher Hunter, chair ... identified the pathways that lead to the production of ...
... Although psychiatrists are among the least religious physicians, they ... and spiritual dimensions of their patients, according to survey ... Journal of Psychiatry. , Ever since Freud described religious ... been tension and at times hostility between religion and ...
... problems with Prilosec and Nexium , , MONDAY, Dec. ... of the popular heartburn drugs Prilosec and Nexium found ... Monday. , The announcement followed a three-month safety review ... preliminary studies. But detailed data from both studies, plus ...
... Dec. 10 JPMorgan,s Annual,Healthcare Conference, which celebrates ... 7-10 at the Westin St. Francis Hotel in ... largest, will feature,presentations from approximately 300 companies, both ... This year,s event will include,panel discussions with leading ...
... mg, * 53% of Patients Treated with 90 mg Dose ... in the Risk of Death ... Compared to Non-responders, ATLANTA, Dec. 10 Pharmion ... data,from the Phase 1/2 study investigating the combined use of MGCD0103, a,novel, ...
Cached Medicine News:Health News:Hypertension Linked to Risk of Mild Cognitive Impairment 2Health News:Researchers led by Penn vet uncover the delicate protein balance behind the immune system response 2Health News:Psychiatrists: Least religious but most interested in patients' religion 2Health News:Psychiatrists: Least religious but most interested in patients' religion 3Health News:Psychiatrists: Least religious but most interested in patients' religion 4Health News:FDA Confirms No Heart Risk From Heartburn Drugs 2Health News:FDA Confirms No Heart Risk From Heartburn Drugs 3Health News:JPMorgan's 26th Annual Healthcare Conference Media Advisory 2Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 2Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 3Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 4Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 5Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 6Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 7
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
(Date:7/30/2015)... N.J. , July 30, 2015 Eisai ... in the United States , European ... FDA, EMA and MHLW, respectively) for eribulin, for the ... who have received prior chemotherapy for advanced or metastatic ... on data from a pivotal global Phase 3 clinical ...
(Date:7/30/2015)... 2015 Takeda Pharmaceutical Company Limited ("Takeda") ... the post-marketing commitment and submissions of data to ... Bladder Cancer Risk Characterization Study , a large ... in four European countries, for pioglitazone containing medicines, ... years of follow-up. Findings demonstrate that there is ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... Reportlinker.com announces that a new market ... , Analysis of the Material ... 2009 was one of ... economy, the material test equipment market being ...
... 2012 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... leading China-based exporter and retailer of high-quality medical dressings ... that it will release financial results for its first ... management will host a conference call to discuss these ...
Cached Medicine Technology:Analysis of the Material Testing Equipment Market 2Winner Medical Group Inc. to Host First Quarter 2012 Earnings Conference Call on Thursday, February 9, 2012 at 08:00 p.m. EST 2
... DiscoverySE Centrifuges. Workhorse. All in one. ... the new Sorvall Discovery 100SE Ultracentrifuge ... features come with top-of-the-line performance, powerful ... all built into the smallest, quietest, ...
... DiscoveryTMM150 SE Micro-ultra centrifuge continues to raise ... processing, now with 1,048,000 x g performance ... DiscoveryTMM150SE processes sample sizes from 0.2 ... floor footprint, brushless direct drive, very quiet ...
... the highest g-force ever. But optimal productivity ... Optima MAX combines maximum force, capacity, and ... that's worlds apart from any other system. ... enhanced efficiency, Optima takes productivity to the ...
... Efficiency, versatility, and environmental safety ... Optima LE-80 K Ultracentrifuge from ... innovative Optima centrifugation technology, the ... cost effectively provide advanced capability ...
Medicine Products: